| ASSET | YEAR | % RETURN |
|---|---|---|
Diversified Energy (DEC) | 2023 | 971.46% |
Applied Opt (AAOI) | 2023 | 895.88% |
American Coastal Insurance (ACIC) | 2023 | 767.82% |
Neuropace (NPCE) | 2023 | 647.1% |
Bit Digital (BTBT) | 2023 | 582.26% |
Eyepoint Pharmaceuticals (EYPT) | 2023 | 550.99% |
MoonLake Immunotherapeutics (MLTX) | 2023 | 469.72% |
Olema Pharmaceuticals (OLMA) | 2023 | 465.73% |
Tourmaline Bio (TRML) | 2023 | 445.72% |
Gyre Therapeutics (GYRE) | 2023 | 388.72% |
NGL Energy Partners (NGL) | 2023 | 384.35% |
Immunome (IMNM) | 2023 | 345.83% |
Pulse Biosciences (PLSE) | 2023 | 341.88% |
Limbach (LMB) | 2023 | 337.63% |
Talkspace (TALK) | 2023 | 312.14% |
Heritage Insurance Hldgs (HRTG) | 2023 | 264.25% |
Aveanna Healthcare (AVAH) | 2023 | 262.16% |
Hovnanian Enterprises (HOV) | 2023 | 261.57% |
Sky Harbour (SKYH) | 2023 | 229.69% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 2023 | 226.7% |
Autolus Therapeutics (AUTL) | 2023 | 222% |
Alpha Technology Group Limited Ordinary Shares (ATGL) | 2023 | 217.5% |
Rxsight (RXST) | 2023 | 214.51% |
MiMedx (MDXG) | 2023 | 210.99% |
Savara (SVRA) | 2023 | 209.21% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
